[
  {
    "ts": "2026-02-19T02:33:53+00:00",
    "headline": "Evercore Notes AbbVie Inc.’s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited",
    "summary": "AbbVie Inc. (NYSE:ABBV) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds. AbbVie Inc. (NYSE:ABBV) tops our list for being one of the most promising stocks. TheFly reported on February 4 that Evercore ISI lowered its price target on ABBV to $228 from $232 and maintained an Outperform rating. The firm noted that although Tremfya […]",
    "url": "https://finance.yahoo.com/news/evercore-notes-abbvie-inc-abbv-023353428.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "c4562fe0-3008-33c3-874e-1ef5db2a6d26",
      "content": {
        "id": "c4562fe0-3008-33c3-874e-1ef5db2a6d26",
        "contentType": "STORY",
        "title": "Evercore Notes AbbVie Inc.’s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited",
        "description": "",
        "summary": "AbbVie Inc. (NYSE:ABBV) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds. AbbVie Inc. (NYSE:ABBV) tops our list for being one of the most promising stocks. TheFly reported on February 4 that Evercore ISI lowered its price target on ABBV to $228 from $232 and maintained an Outperform rating. The firm noted that although Tremfya […]",
        "pubDate": "2026-02-19T02:33:53Z",
        "displayTime": "2026-02-19T02:33:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Evercore Notes AbbVie Inc.'s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aXAa28AvezyRv056g_RUEg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lzVMSqWRbEKelBHS4c050A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/evercore-notes-abbvie-inc-abbv-023353428.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evercore-notes-abbvie-inc-abbv-023353428.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T09:05:00+00:00",
    "headline": "2 Dividend Stocks to Hold for the Next 5 Years",
    "summary": "Income investors can rest easy owning these stocks.",
    "url": "https://www.fool.com/investing/2026/02/19/2-dividend-stocks-to-hold-for-the-next-5-years/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "6ebb6270-f6bc-361c-bc33-eb09bd526123",
      "content": {
        "id": "6ebb6270-f6bc-361c-bc33-eb09bd526123",
        "contentType": "STORY",
        "title": "2 Dividend Stocks to Hold for the Next 5 Years",
        "description": "",
        "summary": "Income investors can rest easy owning these stocks.",
        "pubDate": "2026-02-19T09:05:00Z",
        "displayTime": "2026-02-19T09:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e72259a7bb29dca78c2aa3387c85d5de",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A pipeline over green grass.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T.qSkRL6ExgRfiUaiXm.bg--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/e72259a7bb29dca78c2aa3387c85d5de.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vFxkWM4y4.lsPyWyo3LEug--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e72259a7bb29dca78c2aa3387c85d5de.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/19/2-dividend-stocks-to-hold-for-the-next-5-years/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-dividend-stocks-hold-next-090500234.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T12:15:57+00:00",
    "headline": "Should AbbVie’s (ABBV) Post-Humira Pipeline Progress Prompt a Fresh Look From Investors?",
    "summary": "AbbVie recently reported record 2025 results and outlined a stronger 2026 outlook, while advancing key immunology assets and completing the VOLITE skin quality aesthetics trial to bolster its post-Humira growth profile. These updates, alongside reduced short interest and new Rinvoq regulatory progress, underscore how AbbVie is broadening its earnings base beyond a single flagship franchise. Now we'll examine how the completed VOLITE aesthetics trial and broader pipeline progress may reshape...",
    "url": "https://finance.yahoo.com/news/abbvie-abbv-post-humira-pipeline-121557671.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "0ff757c4-c9df-3b67-8059-5398170bcae9",
      "content": {
        "id": "0ff757c4-c9df-3b67-8059-5398170bcae9",
        "contentType": "STORY",
        "title": "Should AbbVie’s (ABBV) Post-Humira Pipeline Progress Prompt a Fresh Look From Investors?",
        "description": "",
        "summary": "AbbVie recently reported record 2025 results and outlined a stronger 2026 outlook, while advancing key immunology assets and completing the VOLITE skin quality aesthetics trial to bolster its post-Humira growth profile. These updates, alongside reduced short interest and new Rinvoq regulatory progress, underscore how AbbVie is broadening its earnings base beyond a single flagship franchise. Now we'll examine how the completed VOLITE aesthetics trial and broader pipeline progress may reshape...",
        "pubDate": "2026-02-19T12:15:57Z",
        "displayTime": "2026-02-19T12:15:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-post-humira-pipeline-121557671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-post-humira-pipeline-121557671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T14:37:00+00:00",
    "headline": "AbbVie Declares Quarterly Dividend",
    "summary": "The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share.",
    "url": "https://finance.yahoo.com/news/abbvie-declares-quarterly-dividend-143700509.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "7b43554f-19c3-3a0b-8f7a-5b4b6f715b63",
      "content": {
        "id": "7b43554f-19c3-3a0b-8f7a-5b4b6f715b63",
        "contentType": "STORY",
        "title": "AbbVie Declares Quarterly Dividend",
        "description": "",
        "summary": "The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share.",
        "pubDate": "2026-02-19T14:37:00Z",
        "displayTime": "2026-02-19T14:37:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/2e52197b928c7ec1b4704899dd976804",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MUCpLY4z4UP00QfDDTbtxQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/2e52197b928c7ec1b4704899dd976804.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2XP7MbXikG4J0IZRCfs7.Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/2e52197b928c7ec1b4704899dd976804.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-declares-quarterly-dividend-143700509.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-declares-quarterly-dividend-143700509.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T17:35:00+00:00",
    "headline": "3 Stocks to Buy and Hold for 2026 and Beyond",
    "summary": "Any of these three pharmaceutical titans could move the needle in your portfolio.",
    "url": "https://www.fool.com/investing/2026/02/19/3-stocks-to-buy-and-hold-for-2026-and-beyond/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "e2337482-b5a3-332a-a574-8dd73826f2d7",
      "content": {
        "id": "e2337482-b5a3-332a-a574-8dd73826f2d7",
        "contentType": "STORY",
        "title": "3 Stocks to Buy and Hold for 2026 and Beyond",
        "description": "",
        "summary": "Any of these three pharmaceutical titans could move the needle in your portfolio.",
        "pubDate": "2026-02-19T17:35:00Z",
        "displayTime": "2026-02-19T17:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/8fe5776bc79812bf2445b492bd975ca2",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "AbbVie building.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jj.V.j1qDwrK_a4AUr8NgQ--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/8fe5776bc79812bf2445b492bd975ca2.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1InxjxoAt0dvO4CZ1KA.Jw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/8fe5776bc79812bf2445b492bd975ca2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/19/3-stocks-to-buy-and-hold-for-2026-and-beyond/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-stocks-buy-hold-2026-173500068.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]